Congresses
VAVELTA® at FACE - June 2008, London
For the second year running, Intercytex exhibited VAVELTA® at FACE.
Two of the clinical investigators in the Phase II trial for VAVELTA®, Dr David Eccleston from the MediZen Clinic, Birmingham, and Professor Nicholas Lowe from the Cranley Clinic, London, presented preliminary results from their participation in the trial in acne scarring and nasolabial folds respectively. For a summary of the information presented, please click, on the link below.
The website for FACE is: www.cosmeticconference.co.uk
FACE is the largest medical aesthetic conference in the UK, accessible to all practitioners and clinic owners involved in delivering predominantly non-surgical medical aesthetic procedures.
VAVELTA® at the IAAFA - April 2008, London
On 12 April 2008, Dr David Eccleston, Intercytex' Principal Investigator for its Phase II clinical trial being conducted at his clinic in Birmingham in acne scarring, presented at the Annual Conference of the International Academy of Advanced Facial Aesthetics.
The website for the IAAFA is www.iaafa.net
The IAAFA is a not-for-profit organisation dedicated to supporting the work of practitioners in facial aesthetics. Its panel of advisory members represents every branch of the profession and has close links with leading organisations and companies working in facial aesthetics.
VAVELTA® at the AMWC - April 2008, Paris
On 11 April 2008, Dr Paul Kemp, Intercytex' Founder and Chief Scientific Officer presented at the Anti-aging Medicine World Congress on the subject of "Autologous hair regeneration therapy".
The website for the AMWC is www.euromedicom.com
The Anti-Aging Medicine World Congress Scientific Committee is attended by a distinguished array of international experts on anti-ageing medicine, aesthetic surgery and dermatology who seek to learn more about the latest products, information and techniques available in these fields.
VAVELTA® at IMCAS - January 2008, Paris
On 12 January 2008, Dr Paul Kemp, Intercytex' Founder and Chief Scientific Officer presented at the Xth IMCAS Annual Meeting on the subject of cell therapy and the science behind VAVELTA®. Please click on the link below to access a downloadable version of Dr Kemp's presention.
"From Cells to Cell Therapy Paris 2008"
Nick Higgins, Intercytex' Chief Executive Officer, also presented at IMCAS, during the IMCAS Industry Innovation Tribune on 9 January 2008. His talk on how to build a commercially successful business based on regenerative medicine and the key elements required can be accessed by clicking on the link below.
Combining Science and Aesthetics - Investing in Cell Therapy for the Future
The website for IMCAS is www.imcasweb.com
IMCAS has become one of the largest, most influential and most representative of international conferences only dedicated to the field of aesthetic surgery and cosmetic dermatology.
VAVELTA® at FACE - June/July 2007
On 1 July 2007, Dr Paul Kemp presented at FACE on the subject of "From Cells to Cell Therapy". His 20 minute scientific presentation gave the audience an opportunity to hear one of the world's experts on fibroblasts speak about the technology and science behind cellular rejuvenation and repair.
Please click on the link below to access a downloadable version of Dr Kemp's presentation.
The website for FACE is: www.cosmeticconference.co.uk
FACE is the largest medical aesthetic conference in the UK, accessible to all practitioners and clinic owners involved in delivering predominantly non-surgical medical aesthetic procedures.
To view PDFs you need the
Adobe Acrobat Reader. This program is available free of charge from
the Adobe website.
